Ahmad Bakar - Millennium Pharmacon Pres Director
| SDPC Stock | IDR 143.00 4.00 2.72% |
Director
Mr. Ahmad bin Abu Bakar serves as Director of PT Millennium Pharmacon International Tbk since May 23, 2012. He is a registered pharmacist in Malaysia. He obtained Bachelor of Pharmacy from Bradford University, UK . He has over 20 years of pharmaceutical experiences and has worked in various fields of pharmacy, including retail and wholesale pharmacy, manufacturing and private hospital. He has worked with Pharmaniaga Logistics Sdn Bhd . He is a member of Company Management Risk Committee. since 2012.
| Age | 54 |
| Tenure | 12 years |
| Phone | 62 21 270 85961 |
| Web | https://www.mpi-indonesia.co.id |
Millennium Pharmacon Management Efficiency
The company has return on total asset (ROA) of 0.0342 % which means that it generated a profit of $0.0342 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0938 %, meaning that it generated $0.0938 on every $100 dollars invested by stockholders. Millennium Pharmacon's management efficiency ratios could be used to measure how well Millennium Pharmacon manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Agus Soetirto | Bank Rakyat Indonesia | 55 | |
| Troy Modlin | Hanjaya Mandala Sampoerna | 47 | |
| Andre Dahan | Hanjaya Mandala Sampoerna | 47 | |
| Mimi Kurniawan | Hanjaya Mandala Sampoerna | 43 | |
| Ivan Cahyadi | Hanjaya Mandala Sampoerna | 42 | |
| Helmi Satriyono | Garuda Indonesia Persero | 48 | |
| Sophia Alizsa | Bank Rakyat Indonesia | 59 | |
| Fuad Rizal | Garuda Indonesia Persero | N/A | |
| Gatot Mardiwasisto | Bank Rakyat Indonesia | 61 | |
| Novianto Herupratomo | Garuda Indonesia Persero | 55 | |
| Yos Ginting | Hanjaya Mandala Sampoerna | 48 | |
| Nicodemus Lampe | Garuda Indonesia Persero | 56 | |
| Nina Sulistyowati | Garuda Indonesia Persero | 52 | |
| Michael Sandritter | Hanjaya Mandala Sampoerna | 46 | |
| Johannes Wardhana | Hanjaya Mandala Sampoerna | 56 | |
| Vera Lim | Bank Central Asia | 57 | |
| Lianawaty Suwono | Bank Central Asia | 56 | |
| Ho Tan | Bank Central Asia | 62 | |
| Agus Soetirto | Garuda Indonesia Persero | 56 | |
| Donsuwan Simatupang | Bank Rakyat Indonesia | 56 | |
| Daniel Yuwono | Mnc Land Tbk | 46 | |
Management Performance
| Return On Equity | 0.0938 | |||
| Return On Asset | 0.0342 |
Millennium Pharmacon Leadership Team
Elected by the shareholders, the Millennium Pharmacon's board of directors comprises two types of representatives: Millennium Pharmacon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Millennium. The board's role is to monitor Millennium Pharmacon's management team and ensure that shareholders' interests are well served. Millennium Pharmacon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Millennium Pharmacon's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mohamad Hassan, F Director | ||
| Glenn Ariff, Unaffiliated Director | ||
| Aris, Chairman Audit | ||
| Dian Anggreni, Legal and Corporate Secretary | ||
| Ernie Hilal, Corporate Secretary | ||
| Yungkis Sucandra, Head Unit | ||
| Ahmad Bakar, Pres Director | ||
| Mohamad Mukhtar, President Director | ||
| Morsela, Ma Marketing | ||
| Puji Hartono, Head Unit | ||
| Nyoman Rai, Independent Commissioner | ||
| Dedi Martadiredja, Sr Sales | ||
| Ivan Hanafi, Independent Director | ||
| Olga Bolang, Co Sec | ||
| Noraini Ali, Commissioner | ||
| Izzat Othman, President Commissioner, Independent Commissioner | ||
| Yuni Arrivani, Deputy Legal | ||
| Mohamed Rahman, Commissioner |
Millennium Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Millennium Pharmacon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0938 | |||
| Return On Asset | 0.0342 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 828.27 B | |||
| Shares Outstanding | 1.27 B | |||
| Shares Owned By Insiders | 87.94 % | |||
| Shares Owned By Institutions | 3.35 % | |||
| Price To Earning | 9.31 X | |||
| Price To Book | 1.16 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Millennium Pharmacon in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Millennium Pharmacon's short interest history, or implied volatility extrapolated from Millennium Pharmacon options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Millennium Pharmacon International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Millennium Stock analysis
When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |